Awen Oncology Limited
13510573
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 14/07/2021
UNIVERSITY ACADEMIC AND COMPANY CEO
BRITISH · WALES · Age 61
director · Since 13/07/2024
NON EXECUTIVE DIRECTOR
BRITISH · ENGLAND · Age 70
Also on 3 other boards
Persons with Significant Control
Prof Andrea Brancale
Italian · Czech Republic · Age 54
M-Sparc, Parc Gwyddoniaeth Menai, Gaerwen, LL60 6AG
Notified 14/07/2021
CompanyRankvs 378+ SIC 72110 peers76
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2026
Net Worth
£730k
Balance sheet strength
Cash
£683k
Cash in the bank
Net Current Assets
£679k
Working capital
Current Assets
£745k
Current Liabilities
£66k
Fixed Assets
£97k
Debtors
£62k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2026 | 11.25 | +£363k |
| 2025 | 3.35 | -£328k |
| 2024 | 6.50 | +£699k |
| 2023 | — | +£146 |
Derived from filed accounts. Not audited figures.